UC San Francisco – California, USA
Contact person: Matt Baggott, PhD
Drug administration phase completed, eight subjects were given 0.5 and 1.5 mg/kg MDMA HCl. A paper from it is in press at Annals of Internal Medicine. Data was presented at two conferences.
- Harris DS, Baggott M, Mendelson J, Mendelson JE, Jones RT (2002) Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacol (Berl) 162: 396-405.
- Lester SJ, Baggott M, Welm S, Schiller NB, Jones RT, Foster E, Mendelson J (2000) Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial. Ann Intern Med 133: 969-973.